Patient-Specific Induced Pluripotent Stem Cell-Based Disease Model for Pathogenesis Studies and Clinical Pharmacotherapy

Yingxin Li; Karim Sallam; Peter J Schwartz; Joseph C Wu

doi:10.1161/CIRCEP.117.005398

Patient-Specific Induced Pluripotent Stem Cell-Based Disease Model for Pathogenesis Studies and Clinical Pharmacotherapy

Circ Arrhythm Electrophysiol. 2017 Jun;10(6):e005398. doi: 10.1161/CIRCEP.117.005398.

Authors

Yingxin Li¹, Karim Sallam¹, Peter J Schwartz¹, Joseph C Wu²

Affiliations

¹ From the Stanford Cardiovascular Institute, Departments of Medicine and Radiology, Institute of Stem Cell Biology & Regenerative Medicine (Y.L., K.S., J.C.W.), Stanford University, School of Medicine, CA; and Center for Cardiac Arrhythmias of Genetic Origin, IRCCS Istituto Auxologico Italiano, Milano, Italy (P.J.S.).
² From the Stanford Cardiovascular Institute, Departments of Medicine and Radiology, Institute of Stem Cell Biology & Regenerative Medicine (Y.L., K.S., J.C.W.), Stanford University, School of Medicine, CA; and Center for Cardiac Arrhythmias of Genetic Origin, IRCCS Istituto Auxologico Italiano, Milano, Italy (P.J.S.). joewu@stanford.edu.

No abstract available

Keywords: Editorials; cardiovascular diseases; induced pluripotent stem cells; myocytes, cardiac; ryanodine receptor calcium release channel; stem cells.

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Diabetes Mellitus, Type 2*
Drug Evaluation, Preclinical
Humans
Induced Pluripotent Stem Cells*
Ryanodine Receptor Calcium Release Channel
Tachycardia, Ventricular*

Patient-Specific Induced Pluripotent Stem Cell-Based Disease Model for Pathogenesis Studies and Clinical Pharmacotherapy

Authors

Affiliations

Publication types

MeSH terms

Substances

Supplementary concepts

Grants and funding